Trigeminal Neuralgia
📧 Sign up to get email alerts when something new happens for Trigeminal Neuralgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-11-08FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for carbamazepine from Apotex Corp., approving changes to the approved generic product.
-
FDA approval · 2022-10-06FDA Approved: CARBAMAZEPINE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' generic carbamazepine under Original Application ANDA214277.
-
FDA approval · 2022-08-22FDA Approved: CARBAMAZEPINE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the Original Application for generic carbamazepine from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2022-08-18FDA Approved: CARBAMAZEPINE — Original Application (Northstar Rx LLC)
FDA approved the original generic application for Carbamazepine from Northstar Rx LLC, authorizing a generic version of the anticonvulsant. …
-
FDA approval · 2022-03-31FDA Approved: CARBAMAZEPINE ER — Original Application (Bostal LLC)
FDA approved Bostal LLC's original-application generic extended-release carbamazepine (CARBAMAZEPINE ER), marking the first approval of this…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-12-01FDA Approved: CARBATROL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for CARBATROL (carbamazepine) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2021-04-13FDA Approved: CARBAMAZEPINE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith Laboratories' Original Application for carbamazepine (generic) under ANDA213311.
-
FDA approval · 2020-04-24FDA Approved: CARBAMAZEPINE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved Rising Pharma's original application for carbamazepine, a generic anticonvulsant used to treat epilepsy, trigeminal neuralg…
-
FDA approval · 2020-04-15FDA Approved: CARBAMAZEPINE — Original Application (NIVAGEN PHARMACEUTICALS, INC.)
The FDA approved the original application for a generic carbamazepine product from NIVAGEN PHARMACEUTICALS, INC., marking the approval of th…
-
FDA approval · 2020-02-28FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2020-02-28FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for carbamazepine, allowing an additional product authorizat…
-
FDA approval · 2020-02-27FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for EPITOL (carbamazepine). This approval pertains to a supplemental filing for the product…
-
FDA approval · 2018-03-20FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2016-11-08FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc., resulting in changes to the …
-
FDA approval · 2016-11-08FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2015-02-18FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for carbamazepine filed by Apotex Corp., indicating an approved modification to the generic prod…
-
FDA approval · 2015-01-20FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Carbamazepine from Torrent Pharmaceuticals Limited, indicating an approved action on an existing…
-
FDA approval · 2015-01-20FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-09-16FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation. The action updat…
-
FDA approval · 2014-09-16FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol XR (carbamazepine) from Novartis Pharmaceuticals Corporation, resulting in updated labe…
-
FDA approval · 2014-03-18FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)
The FDA approved Apotex Corp.'s supplemental application for carbamazepine, a generic anticonvulsant. This action updates the approval statu…
-
FDA approval · 2014-03-10FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-02-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's supplemental application for carbamazepine, a generic anticonvulsant.
-
FDA approval · 2014-02-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for carbamazepine from Torrent Pharmaceuticals Limited, indicating updated authorization for the…
-
FDA approval · 2014-01-16FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation. The action pertains to c…